Pure Global
NCT06380218

Evaluation of Nutritional Prevention Program for Women's Cardiovascular Health on Quality of Life (SAFE)

Institut Pasteur de Lille·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Healthy Volunteers
Drug/Device/Intervention
Nutrional and physical activity program
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Institut Pasteur de Lille
Location
Lille, France
Timeline & enrollment
Phase
N/A
Start date
Jul 11, 2023
End date
Aug 01, 2025
Enrollment
50 participants
Primary outcome

Change from baseline on quality of life of women with cardiovascular risk at 3 months after a nutritional prevention program associated with the consumption of Primevère margarine

Summary

The objective is to evaluate the effect of a nutritional prevention program associated with
 the consumption of Primevère margarine on the quality of life of women at risk of
 cardiovascular disease after 10 group coaching sessions in nutrition and physical activity.

ICD-10 classifications
Healthy person accompanying sick personRoutine general health check-up of armed forcesRoutine general health check-up of sports teamsRoutine general health check-up of inhabitants of institutions
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06380218
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06380218 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut Pasteur de Lille and is currently Recruiting. The study focuses on Healthy Volunteers. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.